Predictive Oncology Inc. (NASDAQ:POAI) price on Wednesday, Jan 06, dropped -6.46% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.8.
A look at the stock’s price movement, the close in the last trading session was $0.85, moving within a range at $0.7703 and $0.8900. The beta value (5-Year monthly) was 1.66 while the PE ratio in trailing twelve months stood at 0. Turning to its 52-week performance, $5.3 and $0.63 were the 52-week high and 52-week low respectively. Overall, POAI moved 6% over the past month.
Turning to the stock’s technical picture we see that short term indicators suggest on average that POAI is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
In the market, a comparison of Predictive Oncology Inc. (POAI) and its peers suggest the former has performed considerably weaker. Data shows POAI’s intraday price has changed -6.46% in last session and -70.22% over the past year. Comparatively, Cerner Corp (CERN) has moved +0.79% on the day and only +7.96% in the past 12 months. Looking at another peer, we see that 10X Genomics Inc (TXG) price has dipped -0.99% on the day. However, the stock is 84.59% off its price a year ago. Moreover, Invitae Corp (NVTA) is also down -6.46% in trading on the day while keeping a downtrend of -70.22% over the past year. If we look at the PE ratio, we find that Predictive Oncology Inc.’s ratio stands at 0 compared to Cerner Corp’s 30.83 and 10X Genomics Inc’s 0. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.57% and 1.44respectively in the last trading.
If we refocus on Predictive Oncology Inc. (NASDAQ:POAI), historical trading data shows that trading volumes averaged 1.83 Million over the past 10 days and 807.16 Million over the past 3 months. The company’s latest data on shares outstanding shows there are 17.68 Million shares.
As per Thomson Reuters, 10.36% of Predictive Oncology Inc.’s shares are in the hands of company insiders while institutional holders own 2.17% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 270Million on December 14, 2020, giving us a short ratio of 0.37. The data shows that as of December 14, 2020 short interest in Predictive Oncology Inc. (POAI) stood at 1.53% of shares outstanding, with shares short dropping from 343.16 Million registered in November. Current price change has pushed the stock +8.55% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the POAI stock continues to rise going into the next quarter.
Even if you’re not actively in crypto, you deserve to know what’s actually going on..
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.